# Propanc Biopharma (PPCB) — News

PPCB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ppcb/news

## Recent headlines

- [Propanc Biopharma - PRP shows marked reduction in metastatic burden in PDAC models](https://www.ainvest.com/news/propanc-biopharma-prp-shows-marked-reduction-metastatic-burden-pdac-models-2610) — AInvest Wire, Oct 7, 2026
- [Propanc's PRP shows >90% tumor growth inhibition in PDAC](https://www.ainvest.com/news/propanc-prp-shows-90-tumor-growth-inhibition-pdac-2610) — AInvest Wire, Oct 7, 2026
- [Propanc to start phase 1B PRP trial in 1Q 2027](https://www.ainvest.com/news/propanc-start-phase-1b-prp-trial-1q-2027-2610) — AInvest Wire, Oct 7, 2026
- [Propanc Biopharma reports data showing 90% tumor growth inhibition with PRP in pancreatic cancer models, contrasting profile with Revolution Medicines' Daraxonrasib](https://www.ainvest.com/news/propanc-biopharma-reports-data-showing-90-tumor-growth-inhibition-prp-pancreatic-cancer-models-contrasting-profile-revolution-medicines-daraxonrasib-2610) — AInvest Wire, Oct 7, 2026
- [Propanc Biopharma - To initiate phase 1B PRP study in February 2027 for up to 50 patients](https://www.ainvest.com/news/propanc-biopharma-initiate-phase-1b-prp-study-february-2027-50-patients-2609) — AInvest Wire, Sep 16, 2026
  Propanc Biopharma, Inc. (Nasdaq: PPCB) announced plans to initiate a Phase 1b first-in-human (FIH) study of its lead product candidate, PRP, in February 2027 . The open-label, two-part study will enroll up to 50 patients with advanced solid tumors, including pancreatic, ovarian, and refractory…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).